XML 31 R3.htm IDEA: XBRL DOCUMENT v3.25.1
Award Timing Disclosure
 12 Months Ended
Dec. 31, 2024
Aug. 09, 2024
USD ($)
shares
$ / shares
Rate
Award Timing Disclosures [Line Items]    
Award Timing MNPI Disclosure

Equity Award Grant Practices

The Compensation Committee reviews and approves individual equity grants for the named executive officers and Directors, as well as the total number of shares underlying grants made to all employees. The annual equity grants typically are reviewed and approved at the Compensation Committee’s regular meeting during the third quarter of the fiscal year, although sign-on equity awards are generally approved by the Compensation Committee at the time an executive officer commences employment with Bruker. The grant date for the annual equity grants is the date of the Compensation Committee meeting at which they are approved. Administration of equity awards is managed by the Company’s human resources department with specific instructions related to the timing of grants given by the Compensation Committee. The Committee does not take material nonpublic information into account when determining the timing and terms of equity awards. Similarly, we do not time the release of material, non-public information based on equity award grant dates, vesting events, or sale events.

  
Award Timing MNPI Considered false  
MNPI Disclosure Timed for Compensation Value false  
Falko Busse [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Dr. Busse
Underlying Securities | shares   5,486
Exercise Price | $ / shares   $ 62
Fair Value as of Grant Date | $   $ 123,679
Underlying Security Market Price Change | Rate   0.35%
Gerald N. Herman [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Mr. Herman
Underlying Securities | shares   13,742
Exercise Price | $ / shares   $ 68.2
Fair Value as of Grant Date | $   $ 309,805
Underlying Security Market Price Change | Rate   0.35%
Frank H. Laukien [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Dr. Laukien
Underlying Securities | shares   77,255
Exercise Price | $ / shares   $ 68.2
Fair Value as of Grant Date | $   $ 1,583,024
Underlying Security Market Price Change | Rate   0.35%
Mark R. Munch [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Dr. Munch
Underlying Securities | shares   13,666
Exercise Price | $ / shares   $ 62
Fair Value as of Grant Date | $   $ 308,092
Underlying Security Market Price Change | Rate   0.35%
Juergen W. Srega [Member]    
Awards Close in Time to MNPI Disclosures    
Name   Mr. Srega (2
Underlying Securities | shares   15,407
Exercise Price | $ / shares   $ 62
Fair Value as of Grant Date | $   $ 187,500
Underlying Security Market Price Change | Rate   0.35%